Alpelisib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-15244-5MG | 5 mg | 89,00 | Add | |
| HY-15244-1ML | 10mM/1mL | 97,00 | Add | |
| HY-15244-10MG | 10 mg | 115,00 | Add | |
| HY-15244-50MG | 50 mg | 165,00 | Add | |
| HY-15244-100MG | 100 mg | 254,00 | Add | |
| HY-15244-200MG | 200 mg | 445,00 | Add | |
| HY-15244-500MG | 500 mg | 1'014,00 | Add | |
| HY-15244-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kα inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110α/p110γ/p110δ/p110β with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity[1][2][3].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 83.33 mg/mL (ultrasonic) |
| Grade | Clinical information: Launched |
| Purity | 99.95% |
| Molecular Formula | C19H22F3N5O2S |
| Molecular Weight | 441.47 |
| CAS-Number | 1217486-61-7 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
